You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
Presentation: Updating medicine ingredient names: International harmonisation
TGA presentation: ARCS Scientific Congress Sydney, 11-12 May 2016
These presentation papers are provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way.
The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation papers should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.
- Presented by: Jolanta Samoc, Project Manager, Scientific Evaluation Branch
- Presented at: ARCS Scientific Congress Sydney
- Presentation date: 11-12 May 2016
- Presentation summary: From April 2016, TGA will be updating some medicine ingredient names used in Australia to align with names used internationally.
Updating medicine ingredient names: International harmonisation
Scientific Evaluation Branch
ARCS Express Learning, 12 May 2016
Slide 1 - Overview
Be informed: Some medicine ingredient names are changing
- Ingredient terminology
- What are the changes?
- Informing health professionals and consumers
Slide 2 - Ingredient terminology
Australian Approved Names vs ingredient names used internationally
The World Health Organization's International Nonproprietary Names (INN) are the gold standard for medicine ingredient names Updating medicine ingredient names
Slide 3 - What are the changes
Some changes are minor
- Spelling: amoxycillin → amoxicillin
- Spacing: cyanocobalamin(57Co) → cyanocobalamin (57Co)
- Hydration state: carbidopa anhydrous → carbidopa
Slide 4 - What are the changes?
Some changes are more significant → Dual labelling
- lignocaine → lidocaine (lignocaine)
- amethocaine → tetracaine (amethocaine)
- colaspase → asparaginase (colaspase)
Slide 5 - Informing health professionals and consumers
Seen an ingredient you don't recognise?
TGA website - Updating medicine ingredient names
Slide 6 - Discussion and questions
Keep an eye on safety as medicine ingredient names change